u/leila_vasquez

The weekly interval comes out of the half-life — roughly a week — so you are on a smooth curve rather than a series of spikes. That is also why moving your day slightly does very little.

Dropped my injection day by two days once because of travel. Nothing happened. The panic was worse than the effect.

Different laboratories use different assay platforms with different calibration. Comparing across labs adds a systematic offset that is invisible on the report.

STEP-1 ran 68 weeks and landed just under 15% mean body weight change on 2.4mg.

chidi_demir is describing the standard shape here and it matches the trial data better than most anecdotes do.

the food noise going quiet is the effect people actually describe

Brought the whole set to my clinician rather than one flagged value. Completely different conversation.

baseline before you start is worth more than any later panel

Sceptical of the mechanism you are proposing. Gastric emptying slows, it does not stop, and the timings you describe do not follow from it.

Yes — same lab, same fasting state, same rough time of day, or the comparison is doing nothing.

Does constipation track the day after the shot, or is it there all week?

lab reference ranges are not treatment targets

Disagreeing with this bit: that change is confounded by the weight loss itself and cannot be attributed.

I would push back gently. Going up because the scale paused is the single most common mistake described on this board.

I would not draw a line through two points, especially when the second was taken at a different time of day.

valeria_karlsen is right that a reference interval is not a target. It is a description of a population.

Weight change and appetite change are different endpoints on different timescales. Conflating them is where most of the confusion on this board starts.

Adding the obvious one — take it to whoever ordered the panel.

Disagreeing with this bit: that change is confounded by the weight loss itself and cannot be attributed.

draw at the same point in the week if you want comparability

Disagree. 2.4 is the top of the label, not the goal, and "everyone ends up there" is just survivorship in the posts you read.

My triglycerides moved and I spent a fortnight convinced I knew why. The repeat six weeks later was back in range and I had changed nothing.

The appetite thing was the surprise. I expected to feel full. What I got was simply not thinking about food between meals.

That figure is the 68-week trial mean, not a weekly rate. Dividing it by the weeks gives you a number that does not mean anything.

weight loss itself moves several of these independently

Small fix — a reference interval is not a treatment target, and the post above uses them interchangeably.

My stall was eleven weeks. Eleven. Then it moved again without me changing anything at all.

the appetite signal and the scale move on different clocks

Careful. A four-week stall is inside normal variation and treating it as failure is how people escalate for no reason.

The escalation schedule in the trials existed to keep people on the drug. It is a tolerability ramp, and it is why the label reads the way it does.

Genuine question — is the appetite effect still there, or is it just the scale that has paused?

Different laboratories use different assay platforms with different calibration. Comparing across labs adds a systematic offset that is invisible on the report.

Added ApoB to the panel after a thread here. It told me something the standard lipid panel had been hiding.

Weight change and appetite change are different endpoints on different timescales. Conflating them is where most of the confusion on this board starts.